FDA Drug Application (020044) for EXOSURF NEONATAL by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number020044
Product Number001
FormFOR SUSPENSION;INTRATRACHEAL
Dosage12MG/VIAL;108MG/VIAL;8MG/VIAL
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEXOSURF NEONATAL
Active IngredientCETYL ALCOHOL; COLFOSCERIL PALMITATE; TYLOXAPOL



Back to FDA Applications sponsored by GLAXOSMITHKLINE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.